Home Biotechnology Industry News Hyperion Wins NDA Approval for UCD Drug Developed With Support from…

Hyperion Wins NDA Approval for UCD Drug Developed With Support from…

PharmaDirections congratulates Hyperion Therapeutics on achieving an NDA approval for their RAVICTIâ„¢ (glycerol phenylbutyrate) Liquid for Treatment of Urea Cycle Disorders . PharmaDirections is proud...

(PRWeb February 27, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10442980.htm